General · 29 June 2026

Blood test could match patients to obesity drugs

Scientists are exploring how a simple blood test might help tailor weight-loss treatments for severe obesity patients. The test measures two hormones, GLP-1 and GIP, to predict how well drugs like semaglutide or tirzepatide might work. This preliminary study suggests personalising treatment could lead to better weight loss and health improvements.

By BriefTea Editorial · 29 June 2026 at 14:14

Reported by News-Medical · How we write briefs

Get the app

More briefs

GeneralGoogle paying £260m to settle UK Play Store developer lawsuit PoliticsJames Cleverly steps down from the shadow cabinet to campaign for London mayor GeneralThe UK Navy just followed four Russian ships again GeneralSarah Ferguson is moving back to the UK following the Epstein scandal GeneralIcelanders vote on restarting EU membership talks after 13 years GeneralGoogle now auto-expands AI answers, pushing links down Browse all stories →